1297599-75-7

Upstream product

• 1297599-73-5 2-(4-fluoro-benzylidene)-7-methoxy-indan-1-one 
• 1297599-74-6 4-(4-Fluoro-phenyl)-9-methoxy-5H-indeno[1,2-d]pyrimidin-2-ylamine 
• 459-57-4 4-fluorobenzaldehyde 
• 34985-41-6 7-methoxy-indan-1-one 

Downstream Products

• 1297599-56-4 2-Amino-4-(4-fluoro-phenyl)-9-{4-[4-(3,3,3-trifluoro-propyl)-piperazin-1-yl]-phenyl}-indeno[1,2-d]pyrimidin-5-one 
• 1297599-76-8 2-amino-4-(4-fluoro-phenyl)-9-hydroxy-indeno[1,2-d]pyrimidin-5-one 
• 1297599-77-9 trifluoro-methanesulfonic acid 2-amino-4-(4-fluoro-phenyl)-5-oxo-5H-indeno[1,2-d]pyrimidin-9-yl ester 
• 1297599-78-0 2-amino-4-(4-fluoro-phenyl)-9-(4-piperazin-1-yl-phenyl)-indeno[1,2-d]pyrimidin-5-one 
• 1297599-58-6 2-Amino-4-(4-fluoro-phenyl)-9-(3-fluoro-phenyl)-indeno[1,2-d]pyrimidin-5-one 

Relevant academic research and scientific papers

ARYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS

This invention relates to a novel arylindenopyrimidine, A, and its therapeutic and prophylactic uses. Disorders treated and/or prevented include Parkinson's Disease wherein X, R2, R3, and R4 are as defined in the specifica